# Gene Synthesis Market

> Gene Synthesis Market Research Report: Size, Share, Trend Analysis By Applications (Synthetic Biology, Therapeutics, Vaccines, Genetic Engineering, Agricultural Biotechnology), By Product Type (Gene Libraries, Oligonucleotides, Plasmids, Gene Fragments), By Technology (Polymerase Chain Reaction, Microarray Technology, DNA Sequencing, Automated Synthesis), By End Use (Academic Research, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 19.96%
- **2024:** $ 2.62 Billion
- **2025:** $ 3.14 Billion
- **2035:** $ 19.36 Billion
- **Key Players:** Thermo Fisher Scientific(US), Integrated DNA Technologies (US), GenScript (CN), Eurofins Genomics (DE), Twist Bioscience (US), Synthetic Genomics (US), DNA2.0 (US), LGC Biosearch Technologies (GB), Bioneer (KR)

**Report ID:** MRFR/HC/10104-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/gene-synthesis-market-11624

---

## Market Summary

## **Gene Synthesis Market Overview:**

As per MRFR analysis, the Gene Synthesis Market Size was estimated at 2.28 (USD Billion) in 2023. The Gene Synthesis Market Industry is expected to grow from 2.53(USD Billion) in 2024 to 8 (USD Billion) by 2035. The Gene Synthesis Market CAGR (growth rate) is expected to be around 11.03% during the forecast period (2025 - 2035).

### **Key Gene Synthesis Market Trends Highlighted**

The Global Gene Synthesis Market is experiencing significant trends driven by advances in biotechnology and increasing research and development activities across regions. Key market drivers include the growing demand for synthetic genes in pharmaceuticals and agriculture aimed at developing new treatments and improving crop yields. 

The rising application of synthetic biology in diverse fields such as diagnostics, therapeutics, and environmental sustainability is propelling the market forward. Additionally, the increasing number of research institutions and collaborations globally underscores the importance of gene synthesis in various scientific pursuits. Opportunities to be explored encompass the potential for personalized medicine and gene therapies as the healthcare sector increasingly seeks tailored solutions. The collaboration between academic institutions and businesses is fostering innovation and creativity in gene synthesis technologies, enabling faster and more efficient production processes.

As the market evolves, there is an increasing emphasis on automation and artificial intelligence, which could enhance accuracy and reduce turnaround times in gene synthesis. Trends in recent times indicate a notable shift towards the adoption of CRISPR technology and genome editing techniques within synthetic biology.

This requires a steady supply of synthesized genes, thus driving market growth. Furthermore, the regulatory environments across different countries are becoming more conducive to gene synthesis research, promoting international collaboration and data sharing among scientists. Overall, the Global Gene Synthesis Market is poised for growth, with expanding applications and technological advancements creating a dynamic environment for industry stakeholders.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Gene Synthesis Market Drivers**

### **Increasing Demand for Synthetic Biology**

The increasing demand for synthetic biology applications is driving a significant acceleration in the global gene synthesis market. Designing and building new biological components and systems is made easier by synthetic biology, which has important ramifications for biomanufacturing, agriculture, and medicines. The synthetic biology industry is expected to expand at a compound annual growth rate of around 25.69%, from USD 7.1 billion in 2017 to USD 40.8 billion by 2025, according to research released by the European Association for Bioindustries. 

Large institutions like Harvard University and the National Aeronautics and Space Administration (NASA) are making significant investments in synthetic biology projects, which are boosting international research efforts and spurring advancements in gene synthesis technology. This increased interest is crucial since it advances [genetic engineering](../../../reports/genetic-engineering-market-1528) and editing, which helps the global gene synthesis market industry expand overall.

### **Technological Advancements in Gene Synthesis**

Rapid technological advancements in gene synthesis methodologies are significantly fueling growth within the Global Gene Synthesis Market Industry. Next-generation sequencing and advanced polymerase chain reaction technologies allow for the fast and accurate synthesis of DNA sequences. The National Institutes of Health reported that the costs of sequencing a human genome declined from nearly USD 100 million in 2001 to less than USD 1,000 in 2021, thereby making genetic research more accessible.

Companies like Illumina Inc. and Thermo Fisher Scientific are continuously developing and refining their technologies, ensuring that researchers have access to robust and efficient tools for gene synthesis, thereby catalyzing further innovation in biotechnology sectors.

### **Rising Applications in Personalized Medicine**

Personalized medicine is becoming a major driver of the Global Gene Synthesis Market Industry. With advancements in genomic medicine and biological research, the applications of gene synthesis are becoming increasingly sophisticated. The World Health Organization has highlighted the importance of personalizing treatment based on genetic information, forecasting that by 2025, personalized medicine could create a market value of around USD 2.5 trillion globally.

Companies such as BGI Genomics and GeneDx are committed to promoting genetic testing services that enable tailored treatments to improve patient outcomes. This endeavor not only reflects the market's growth potential but also highlights the relevance of gene synthesis in redefining treatment paradigms globally.

## **Gene Synthesis Market Segment Insights:**

### **Gene Synthesis Market Application Insights**

The Global Gene Synthesis Market is witnessing significant growth across various applications, which play vital roles in advancing fields such as healthcare, agriculture, and synthetic biology. In 2024, the market is generated a revenue of 2.53 USD Billion and is projected to reach 8.0 USD Billion by 2035, reflecting the increasing demand for precision in genetic modification and design. Within this expansive market, key applications like Synthetic Biology, Therapeutics, Vaccines, Genetic Engineering, and Agricultural Biotechnology are driving substantial contributions.

Synthetic Biology is anticipated to hold a major share of the market with a valuation of 0.76 USD Billion in 2024, expanding to 2.4 USD Billion by 2035, as it not only focuses on designing new biological parts but also enhances existing systems for practical use. The Therapeutics application is valued at 0.63 USD Billion in 2024 and is set to grow to 1.85 USD Billion by 2035, indicating a strong emphasis on personalized medicine and targeted treatments, which reflect the need for advanced solutions in healthcare.

Vaccines, critical during health crises, are projected to generate 0.48 USD Billion in 2024 and reach 1.44 USD Billion by 2035, underscoring the essentiality of rapid vaccine development and production in combating infectious diseases.

Genetic Engineering, pivotal in modifying organisms for various purposes, is set to be valued at 0.42 USD Billion in 2024, growing to 1.26 USD Billion by 2035, which emphasizes its key role in creating genetically modified organisms (GMOs) and improving livestock and crops for higher yield. Furthermore, Agricultural Biotechnology, while currently the smallest segment at 0.24 USD Billion in 2024, is expected to grow to 0.75 USD Billion by 2035, highlighting the increasing focus on improving food security through genetically enhanced crops.

This collective growth across application sectors reflects the broad and transformative potential of gene synthesis technologies in addressing global challenges. 

As the need for sustainable agricultural practices and efficient healthcare solutions intensifies, investments in these applications are likely to rise, contributing to the ongoing evolution of the Global Gene Synthesis Market industry. The prevailing trends, growth drivers, and challenges are closely linked to the advancement of scientific research, regulatory frameworks, and the continuous demand for innovative solutions in diverse sectors.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Gene Synthesis Market Product Type Insights**

The Global Gene Synthesis Market is poised for significant growth, with a valuation of 2.53 USD Billion in 2024, expanding to 8.0 USD Billion by 2035, reflecting the increasing demand for advanced genetic engineering technologies. Within this market, various product types play crucial roles, particularly Gene Libraries, Oligonucleotides, Plasmids, and Gene Fragments. Gene Libraries enable researchers to access a wide array of genetic sequences, fostering innovation and applications in synthetic biology and biotechnology. 

Oligonucleotides, essential components in gene synthesis, are widely utilized in research and clinical applications, driving substantial interest in the market.Plasmids serve as vital tools in gene cloning and genetic manipulation, highlighting their dominance and importance in the biotechnology landscape. Gene Fragments are integral for various synthetic applications, enabling precise control over genetic engineering processes. The market trends indicate growing investments in Research and Development and breakthroughs in genetic engineering are anticipated to propel the Global Gene Synthesis Market revenue further.

Challenges in regulation and quality control remain, yet the market continues to thrive, presenting opportunities for innovations and strategic partnerships.The Global Gene Synthesis Market statistics underscore a dynamic industry landscape characterized by rapid advancements and evolving consumer needs.

### **Gene Synthesis Market Technology Insights**

The Global Gene Synthesis Market shows significant promise within the Technology segment, valued at 2.53 USD Billion in 2024 and grow to 8.0 USD Billion by 2035. This growth trajectory highlights the increasing demand for advanced genetic engineering solutions. Within this segment, various technologies play crucial roles, with Polymerase Chain Reaction being essential for amplifying DNA samples, thus enabling precise analysis. Microarray Technology facilitates the simultaneous analysis of thousands of genes, revolutionizing research applications. DNA Sequencing is a fundamental tool for understanding genetic information, driving advances in personalized medicine and biotechnology.

Automated Synthesis is gaining traction for its efficiency, significantly reducing time in genetic research and application. The intersection of these technologies fosters innovation in the Global Gene Synthesis Market, with continual advancements driving market growth and capturing the interest of researchers and institutions globally. 

Factors such as increased funding for Research and Development, along with the rising prevalence of genetic disorders, underscore the growing importance of these technologies in addressing global health challenges.As the market evolves, it presents numerous opportunities for stakeholders seeking to contribute to biotechnological advancements.

### **Gene Synthesis Market End Use Insights**

The Global Gene Synthesis Market revenue is gaining momentum as it captures the interests of various End Use sectors. In 2024, the market is valued at 2.53 USD Billion, with significant contributions from Academic Research, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations. Academic Research plays a crucial role in driving innovation in gene manipulation, while Pharmaceutical Companies leverage gene synthesis to expedite drug discovery and development. Biotechnology Companies focusing on synthetic biology are transforming the production of biologics and therapeutics, and Contract Research Organizations enhance efficiencies through outsourcing services.

The market growth in these sectors is fueled by increasing investments in Research and Development, technological advancements, and the rise of personalized medicine. However, challenges such as regulatory hurdles and high costs remain. Opportunities abound in emerging markets and the continued evolution of gene synthesis technologies as organizations seek to capitalize on the expanding applications of engineered genes in diagnostics, agriculture, and environmental management. The Global Gene Synthesis Market statistics indicate a robust evolution, well-aligned with the dynamic landscape of genetic engineering.

### **Gene Synthesis Market Regional Insights**

The Global Gene Synthesis Market is showing significant revenue potential across various regions, with North America leading the way. In 2024, North America is valued at 1.2 USD Billion and is projected to reach 4.0 USD Billion by 2035, showcasing its dominant position in advancements in biomedical research and biotechnology. Europe follows with a valuation of 0.8 USD Billion in 2024 and a forecast of 2.5 USD Billion by 2035, bolstered by strong Research and Development initiatives and academic collaborations.

The APAC region, valued at 0.4 USD Billion in 2024, is expected to grow to 1.4 USD Billion by 2035, driven by increasing investments in healthcare infrastructure and genetic research innovations. South America and the MEA regions, while smaller, with valuations of 0.06 USD Billion and 0.07 USD Billion in 2024, respectively, are anticipated to expand their influence in the market by nurturing local biotechnology firms and fostering a supportive regulatory environment.

Overall, the Global Gene Synthesis Market segmentation illustrates a diverse landscape, with North America and Europe exhibiting majority holdings, while the emerging markets in APAC, South America, and MEA provide significant growth opportunities driven by regional initiatives and healthcare demands.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Gene Synthesis Market Key Players and Competitive Insights:**

The Global Gene Synthesis Market has seen tremendous growth and innovation due to advancements in biotechnology and personalized medicine. As the demand for synthetic genes continues to escalate across various sectors, including pharmaceuticals, agriculture, and synthetic biology, numerous players are emerging in the market, each vying for a competitive edge. Companies are increasingly investing in research and development to harness advanced technologies such as next-generation sequencing and CRISPR to enhance accuracy, speed, and scalability in gene synthesis. 

The competitive landscape is defined by firms engaging in strategic collaborations, mergers, acquisitions, and partnerships aimed at strengthening their market presence and expanding their product offerings. This dynamic market environment fosters innovation and elevates the quality of services available, ultimately driving growth and competition among key stakeholders. Molecular Assemblies has carved out a niche within the Global Gene Synthesis Market, leveraging its proprietary technology that enables high-fidelity synthesis of longer DNA strands. The company's strength lies in its efficient and reliable workflows that markedly reduce the time and errors associated with traditional methods.

By offering superior-quality synthetic DNA at scalable levels, Molecular Assemblies positions itself as a favored partner for biotech firms and academic institutions. 

Additionally, the company has focused on developing relationships within specific sectors that benefit from high-quality gene synthesis, such as therapeutics and synthetic biology, further amplifying its influence in the global market. With a commitment to sustainability and efficiency, Molecular Assemblies has set a benchmark in the market, making significant strides that enhance its competitiveness. Genscript is a formidable player in the Global Gene Synthesis Market, known for its comprehensive portfolio of services that cater to the needs of researchers and developers across various industries.

The company excels in providing high-quality gene synthesis, custom DNA products, and cloning services, which are complemented by its advanced technology platforms. Genscript’s key strengths include its extensive experience in molecular biology, large-scale production capabilities, and robust customer support. The company maintains a strong global presence, bolstered by a series of strategic mergers and acquisitions that have expanded its technological capabilities and market reach. Recently, Genscript has focused on enhancing its service offerings through innovations in automation and workflow solutions, ensuring that it remains at the forefront of customer satisfaction in the gene synthesis arena.

Its commitment to quality and operational excellence makes Genscript a critical competitor in the continually evolving landscape of gene synthesis globally.

### **Key Companies in the Gene Synthesis Market Include:**

- [Molecular Assemblies](https://go.trilinkbiotech.com/molecular-assemblies)
- Genscript
- SRI BiosciencesThermo Fisher Scientific
- Codex Biotechnology
- Integrated DNA Technologies
- Synlogic
- Twist Bioscience
- Illumina
- DNA2.0
- Aldevron
- Assembly Biosciences
- Eurofins Genomics
- Biosynthesis
- Genewiz

## **Gene Synthesis Market Industry Developments**

Recent developments in the Global Gene Synthesis Market highlight a notable surge in investments and technological advancements. Companies such as Molecular Assemblies and Genscript continue to innovate, with a focus on improving the efficiency and accuracy of gene synthesis. In September 2023, Thermo Fisher Scientific announced a strategic collaboration with Illumina to enhance genomic solutions, demonstrating a push towards integrated service offerings. Additionally, Codex Biotechnology reported growth in demand for its custom DNA synthesis, pointing to a broader trend in personalized medicine. 

Recent mergers and acquisitions include the acquisition of DNA2.0 by Twist Bioscience in July 2022, which enhanced Twist’s capabilities in gene synthesis and market reach. Eurofins Genomics has also gained significant traction, marking its footprint in the synthetic biology landscape with recent investments. The market saw a valuation increase driven by the rising demand in the biotechnology and pharmaceutical sectors, reflected by increased production capacities by companies like Integrated DNA Technologies and Synlogic.

Over the past few years, the overall market has benefited from heightened interest in genetic engineering, particularly in 2021 and 2022, with increasing funding directed towards Research and Development initiatives across the globe.

## **Gene Synthesis Market Segmentation Insights**

### **Gene Synthesis Market Application****Outlook**

- Synthetic Biology
- Therapeutics
- Vaccines
- Genetic Engineering
- Agricultural Biotechnology

### **Gene Synthesis Market Product Type****Outlook**

- Gene Libraries
- Oligonucleotides
- Plasmids
- Gene Fragments

### **Gene Synthesis Market Technology****Outlook**

- Polymerase Chain Reaction
- Microarray Technology
- DNA Sequencing
- Automated Synthesis

### **Gene Synthesis Market End Use****Outlook**

- Academic Research
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations

### Gene Synthesis Market Regional Outlook

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Rising Investment in Genomic Research

Investment in genomic research is a key driver for the Gene Synthesis Market. As governments and private entities allocate substantial funding towards genomics, the demand for gene synthesis services is likely to increase. Recent reports indicate that funding for genomic research has reached unprecedented levels, with billions of dollars being invested annually. This influx of capital supports various projects, including personalized medicine and genetic engineering, which rely heavily on gene synthesis technologies. The Gene Synthesis Market stands to benefit from this trend, as researchers require high-quality synthesized genes to facilitate their studies and applications.

### Growing Demand for Personalized Medicine

The Gene Synthesis Market is significantly influenced by the rising demand for personalized medicine. As healthcare shifts towards more individualized treatment approaches, the need for tailored genetic solutions becomes increasingly apparent. Personalized medicine relies on understanding the genetic makeup of patients, which necessitates the synthesis of specific genes for therapeutic purposes. The market for personalized medicine is expected to expand rapidly, with projections indicating a growth rate of approximately 15% annually. This trend underscores the importance of the Gene Synthesis Market in providing the necessary tools and technologies to support the development of customized therapies.

### Advancements in Gene Editing Technologies

Recent advancements in gene editing technologies, such as CRISPR and TALEN, are propelling the Gene Synthesis Market forward. These technologies require precise gene synthesis to create the necessary components for effective editing. As researchers and companies adopt these innovative methods, the demand for high-quality synthesized genes is likely to increase. The market is witnessing a shift towards more efficient and cost-effective gene synthesis solutions, which are essential for the successful application of gene editing techniques. This trend indicates a robust growth trajectory for the Gene Synthesis Market as it adapts to the evolving needs of the scientific community.

### Increasing Applications in Synthetic Biology

The Gene Synthesis Market is experiencing a surge in demand due to the expanding applications in synthetic biology. This field encompasses a variety of sectors, including agriculture, pharmaceuticals, and biofuels. As researchers and companies seek to engineer organisms for specific purposes, the need for precise gene synthesis becomes paramount. The market is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 20% in the coming years. This growth is driven by the increasing focus on developing sustainable solutions and innovative products that can address global challenges. Consequently, the Gene Synthesis Market is poised to play a crucial role in advancing synthetic biology initiatives.

### Expansion of Biotechnology and Pharmaceutical Industries

The expansion of the biotechnology and pharmaceutical industries is a significant driver for the Gene Synthesis Market. As these sectors continue to grow, the demand for gene synthesis services is expected to rise correspondingly. The biotechnology industry alone has seen substantial growth, with revenues projected to reach hundreds of billions in the next few years. This growth is fueled by the increasing need for novel therapeutics, vaccines, and diagnostic tools, all of which rely on gene synthesis technologies. Consequently, the Gene Synthesis Market is well-positioned to capitalize on the burgeoning opportunities presented by these expanding industries.

## Future Outlook

The Gene Synthesis Market is projected to grow at a 19.96% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for synthetic genes, and rising applications in therapeutics.

**New opportunities:**

- Development of customized gene synthesis platforms for [personalized medicine.](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937) Expansion into emerging markets with tailored gene synthesis solutions. Partnerships with biotech firms for co-development of novel gene therapies.

By 2035, the Gene Synthesis Market is expected to be robust, reflecting substantial growth and innovation.

## Segment Insights

### By Application: Synthetic Biology (Largest) vs. Therapeutics (Fastest-Growing)

In the Gene Synthesis Market, the application segment is primarily driven by Synthetic Biology, which has emerged as the largest player, leveraging advancements in genomic technologies. This segment encompasses a diverse range of applications, contributing significantly to the overall market landscape. In contrast, Therapeutics stands out as the fastest-growing category, fueled by increasing investment in personalized medicine solutions and the expansion of gene editing technologies that cater to a range of health conditions.

Synthetic Biology (Dominant) vs. Therapeutics (Emerging)

Synthetic Biology is a dominant force within the Gene Synthesis Market, characterized by its broad applicability across various industries, including healthcare and agriculture. This segment enables the design and construction of new biological parts, devices, and systems, thus driving innovation and efficiency. Conversely, the Therapeutics segment is emerging dynamically, focusing on gene therapies and personalized treatments. It is characterized by rapid advancements, responding swiftly to the needs of modern medicine and offering solutions to long-standing medical challenges. Both segments are integral to the market's growth trajectory.

### By Product Type: Oligonucleotides (Largest) vs. Gene Fragments (Fastest-Growing)

The Gene Synthesis Market exhibits a diverse distribution across its product types, with oligonucleotides holding the largest market share due to their extensive applications in research and development. This segment benefits from a variety of uses, including synthetic biology, therapeutic applications, and diagnostics, making it a critical component of the market. In contrast, gene fragments are gaining traction and are recognized as the fastest-growing segment, attributed to their increasing utility in genetic engineering and CRISPR technologies, positioning this segment for rapid expansion in the forthcoming years.

Oligonucleotides (Dominant) vs. Gene Fragments (Emerging)

Oligonucleotides dominate the Gene Synthesis Market owing to their versatility and established role across numerous applications, including DNA sequencing, molecular diagnostics, and as therapeutic agents. Their demand is continuously heightened by advancements in synthetic biology, where precise and customizable sequences are essential. On the other hand, gene fragments represent an emerging opportunity within the market, reflecting a surge in demand for modular gene constructs in genome editing. These segments are increasingly utilized in synthetic and metabolic engineering, unlocking new potential in biopharmaceutical development and personalized medicine, thus driving innovation and market dynamics favorably.

### By Technology: DNA Sequencing (Largest) vs. Automated Synthesis (Fastest-Growing)

The gene synthesis market is segmented into key technologies: Polymerase Chain Reaction, Microarray Technology, DNA Sequencing, and Automated Synthesis. Among these, DNA Sequencing holds the largest market share, driven by its wide applications in genomics, diagnostics, and personalized medicine. Automated Synthesis, on the other hand, is rapidly gaining traction, making it the fastest-growing segment as laboratories increasingly adopt automation for efficiency in genome assembly and synthesis processes.

Technology: DNA Sequencing (Dominant) vs. Automated Synthesis (Emerging)

DNA Sequencing has established itself as the dominant technology in the gene synthesis market due to its critical role in advancing genetic research and applications. Its precision and ability to analyze vast amounts of genetic data make it indispensable for various fields, including clinical diagnostics and therapeutic development. Conversely, Automated Synthesis is an emerging player, characterized by its innovative advancements in streamlining gene synthesis processes. By enabling faster and more accurate synthesis of genes, it caters to the growing demand for rapid and cost-effective genetic material production. This technological shift is pivotal for research institutions and biotechnology companies aiming to stay competitive in the evolving landscape of genetic research.

### By End Use: Pharmaceutical Companies (Largest) vs. Academic Research (Fastest-Growing)

In the Gene Synthesis Market, the distribution of market share among end-use segments is significantly weighted towards pharmaceutical companies, which dominate the landscape due to their robust R&D activities and the growing demand for personalized medicine. Following closely, biotechnology companies play a crucial role in utilizing synthesized genes for innovative healthcare solutions. Academic research institutions, while smaller in market share, are gaining momentum as they increasingly adopt gene synthesis technologies for advanced studies in molecular biology and genetics. The growth trends within the Gene Synthesis Market are primarily driven by the increasing applications of synthetic genes in drug development, diagnostics, and therapeutic research. Pharmaceutical companies are leveraging these advancements to expedite the discovery of novel drugs, while academic institutions are experiencing rapid growth as they expand their research capabilities. This dynamic interplay showcases a promising trajectory for both dominant and emerging segments, highlighting the potential for collaboration and innovation in the years to come.

Academic Research (Emerging) vs. Contract Research Organizations (Dominant)

The Academic Research segment in the Gene Synthesis Market represents an emerging force, characterized by a surge in research activities focused on genetics and synthetic biology. Universities and research institutions are increasingly integrating gene synthesis into their studies, driven by funding initiatives and the need for advanced analytical techniques. This segment is likely to witness growth as more academic institutions invest in gene synthesis tools to enhance their research capabilities. On the other hand, Contract Research Organizations (CROs) serve as a dominant force in this market, offering outsourced research services to pharmaceutical and biotechnology companies. They play a pivotal role in facilitating gene synthesis processes, providing specialized expertise and accelerating project timelines, thus securing their position as essential partners in the gene synthesis landscape.

## Regional Market Share Analysis

### North America : Innovation and Leadership Hub

North America leads the gene synthesis market, holding approximately 45% of the global share, driven by advanced research facilities, significant investments in biotechnology, and a robust regulatory framework. The demand for synthetic genes is propelled by applications in pharmaceuticals, agriculture, and synthetic biology. The U.S. is the largest market, followed closely by Canada, which contributes around 15% to the regional market share. The competitive landscape is characterized by major players such as Thermo Fisher Scientific, Integrated DNA Technologies, and Twist Bioscience, which are at the forefront of innovation. The presence of numerous biotech startups and established gene synthesis companies fosters a dynamic environment for growth. Regulatory support from agencies like the FDA further enhances market stability and encourages research and development initiatives.

### Europe : Emerging Market with Regulations

As per the market synthesis, Europe is witnessing significant growth in the gene synthesis market, accounting for approximately 30% of the global share. The region benefits from stringent regulatory frameworks that ensure quality and safety in biotechnology applications. Countries like Germany and the UK are leading the market, with Germany holding about 12% of the share, driven by strong research institutions and funding initiatives. The competitive landscape includes key players such as Eurofins Genomics and LGC Biosearch Technologies, which are expanding their capabilities to meet rising demand. The European market is also characterized by collaborations between academia and industry, fostering innovation. The European Medicines Agency emphasizes the importance of regulatory compliance in biotechnology, which further supports market growth.

### Asia-Pacific : Rapid Growth and Innovation

biotechnology, rising healthcare needs, and a growing number of research institutions. China is the largest market in the region, contributing approximately 12%, followed by Japan and South Korea, which are also expanding their biotech sectors. The competitive landscape is evolving, with gene synthesis companies like GenScript and Bioneer leading the charge. The region is witnessing a surge in collaborations between local firms and international players, enhancing technological advancements. Government initiatives aimed at boosting research and development in biotechnology further support the market's growth trajectory, positioning Asia-Pacific as a key player in the global landscape.

### Middle East and Africa : Untapped Potential and Growth

The Middle East and Africa region is gradually emerging in the gene synthesis market, currently holding about 5% of the global share. The growth is primarily driven by increasing investments in healthcare and biotechnology, alongside a rising demand for genetic research. Countries like South Africa and the UAE are leading the market, with initiatives aimed at enhancing research capabilities and fostering innovation in biotechnology. The competitive landscape is still developing, with a few key players beginning to establish their presence. Local firms are increasingly collaborating with international companies to leverage expertise and technology. Government support for biotechnology initiatives is crucial for market growth, as it encourages investment and research in the region, paving the way for future advancements.

## Competitive Benchmarking

The Gene Synthesis Market is currently characterized by a dynamic competitive landscape, driven by advancements in biotechnology and increasing demand for synthetic genes across various applications, including pharmaceuticals, agriculture, and industrial biotechnology. Key players such as Thermo Fisher Scientific (US), Integrated DNA Technologies (US), and GenScript (CN) are strategically positioned to leverage their technological capabilities and extensive product portfolios. These companies focus on innovation and partnerships to enhance their market presence, thereby shaping a competitive environment that is both collaborative and competitive. In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce lead times. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Twist Bioscience (US) and Synthetic Genomics (US) suggests a trend towards consolidation, as these firms seek to expand their operational capabilities and geographic reach. In August 2025, Thermo Fisher Scientific (US) announced a strategic partnership with a leading academic institution to develop next-generation gene synthesis technologies. This collaboration is expected to accelerate innovation in gene editing and synthetic biology, positioning Thermo Fisher at the forefront of emerging biotechnological advancements. The partnership underscores the importance of academic-industry collaborations in driving research and development in the gene synthesis sector. In September 2025, Integrated DNA Technologies (US) launched a new line of high-fidelity gene synthesis products aimed at enhancing the accuracy and efficiency of synthetic gene construction. This product launch not only reflects the company's commitment to innovation but also addresses the growing demand for precision in genetic engineering applications. By expanding its product offerings, Integrated DNA Technologies strengthens its competitive position in a rapidly evolving market. In July 2025, GenScript (CN) expanded its global footprint by establishing a new manufacturing facility in Europe. This strategic move is likely to enhance GenScript's ability to meet the increasing demand for gene synthesis services in the region, while also reducing shipping times and costs. The establishment of this facility indicates a proactive approach to regional expansion, which is crucial for maintaining competitiveness in the global market. As of October 2025, the Gene Synthesis Market is witnessing significant trends such as digitalization, sustainability, and the integration of artificial intelligence in research and development processes. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in driving innovation. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on technological innovation, supply chain reliability, and sustainable practices, thereby redefining the parameters of success in the gene synthesis arena.

## Recent News & Developments

Recent developments in the Global Gene Synthesis Market highlight a notable surge in investments and technological advancements. Gene synthesis companies such as Molecular Assemblies and Genscript continue to innovate, with a focus on improving the efficiency and accuracy of gene synthesis. In September 2023, Thermo Fisher Scientific announced a strategic collaboration with Illumina to enhance genomic solutions, demonstrating a push towards integrated service offerings. Additionally, Codex Biotechnology reported growth in demand for its custom DNA synthesis, pointing to a broader trend in personalized medicine.

Recent mergers and acquisitions include the acquisition of DNA2.0 by Twist Bioscience in July 2022, which enhanced Twist’s capabilities in gene synthesis and market reach. Eurofins Genomics has also gained significant traction, marking its footprint in the synthetic biology landscape with recent investments. The market saw a valuation increase driven by the rising demand in the biotechnology and pharmaceutical sectors, reflected by increased production capacities by companies like Integrated DNA Technologies and Synlogic.

Over the past few years, the gene market has benefited from heightened interest in genetic engineering, particularly in 2021 and 2022, with increasing funding directed towards Research and Development initiatives across the globe.

## Report Scope

| MARKET SIZE 2024 | 2.615(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 3.137(USD Billion) |
| MARKET SIZE 2035 | 19.36(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 19.96% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), Integrated DNA Technologies (US), GenScript (CN), Eurofins Genomics (DE), Twist Bioscience (US), Synthetic Genomics (US), DNA2.0 (US), LGC Biosearch Technologies (GB), Bioneer (KR) |
| Segments Covered | Applications, Product Type, Technology, End Use, Regional |
| Key Market Opportunities | Advancements in synthetic biology drive demand for customized gene synthesis solutions in diverse applications. |
| Key Market Dynamics | Rising demand for personalized medicine drives innovation and competition in the gene synthesis market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Gene Synthesis Market as of 2024?**
A: The Gene Synthesis Market was valued at 2.615 USD Billion in 2024.

**Q: What is the projected market size for the Gene Synthesis Market in 2035?**
A: The market is projected to reach 19.36 USD Billion by 2035.

**Q: What is the expected CAGR for the Gene Synthesis Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Gene Synthesis Market during 2025 - 2035 is 19.96%.

**Q: Which application segment is anticipated to have the highest valuation by 2035?**
A: The Therapeutics application segment is expected to reach 4.5 USD Billion by 2035.

**Q: What are the projected revenues for Oligonucleotides by 2035?**
A: Oligonucleotides are projected to generate revenues of 6.5 USD Billion by 2035.

**Q: Which technology segment is likely to see significant growth by 2035?**
A: DNA Sequencing technology is likely to reach a valuation of 4.0 USD Billion by 2035.

**Q: What is the expected market size for Academic Research in 2035?**
A: The Academic Research segment is expected to reach 3.5 USD Billion by 2035.

**Q: Who are the key players in the Gene Synthesis Market?**
A: Key players include Thermo Fisher Scientific, Integrated DNA Technologies, and GenScript, among others.

**Q: What is the projected valuation for Gene Libraries by 2035?**
A: Gene Libraries are projected to reach a valuation of 2.5 USD Billion by 2035.

**Q: How does the Gene Synthesis Market's growth compare across different end-use segments?**
A: Pharmaceutical Companies are expected to lead with a valuation of 5.0 USD Billion by 2035, followed by Biotechnology Companies at 4.0 USD Billion.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gene-synthesis-market-11624*